论文部分内容阅读
目的:分析研究乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果。方法:选取2014年5月至2016年5月间在我院接受治疗的48例重症急性胰腺炎患者为研究对象,随机将其分成对照组和观察组,对照组患者采用乌司他丁进行治疗,观察组患者采用乌司他丁联合奥曲肽进行治疗;对比分析两组患者的治疗效果。结果:采用乌司他丁联合奥曲肽治疗的观察组总有效率为95.83%远高于采用乌司他丁治疗的79.17%,比较差异值P<0.05,具有统计学意义。结论:采用乌司他丁联合奥曲肽治疗重症急性胰腺炎,具有显著的治疗有效率,提高患者的治疗质量,具有较高的治疗药用价值,值得临床推广。
Objective: To analyze the clinical effect of ulinastatin combined with octreotide in the treatment of severe acute pancreatitis. Methods: Forty-eight patients with severe acute pancreatitis who were treated in our hospital from May 2014 to May 2016 were selected and randomly divided into control group and observation group. Patients in the control group were treated with ulinastatin , The observation group patients with ulinastatin combined with octreotide treatment; comparative analysis of the treatment effect of two groups of patients. Results: The total effective rate of the observation group treated with ulinastatin combined with octreotide was 95.83%, which was significantly higher than 79.17% of those treated with ulinastatin. The difference was significant (P <0.05). Conclusion: The combination of ulinastatin and octreotide for severe acute pancreatitis has significant therapeutic efficiency and improve the quality of treatment in patients with high therapeutic value, which is worthy of clinical promotion.